87 related articles for article (PubMed ID: 20546992)
1. In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer.
Zhou L; Li X; Chen X; Li Z; Liu X; Zhou S; Zhong Q; Yi T; Wei Y; Zhao X; Qian Z
Cancer Lett; 2010 Nov; 297(1):56-64. PubMed ID: 20546992
[TBL] [Abstract][Full Text] [Related]
2. The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.
Zhou L; Du L; Chen X; Li X; Li Z; Wen Y; Li Z; He X; Wei Y; Zhao X; Qian Z
Oncol Rep; 2010 Oct; 24(4):941-8. PubMed ID: 20811674
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.
Li Z; Li X; Cao Z; Xu Y; Lin H; Zhao Y; Wei Y; Qian Z
Oncol Rep; 2012 Apr; 27(4):1035-40. PubMed ID: 22245938
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model.
Liu XP; Zhou ST; Li XY; Chen XC; Zhao X; Qian ZY; Zhou LN; Li ZY; Wang YM; Zhong Q; Yi T; Li ZY; He X; Wei YQ
J Exp Clin Cancer Res; 2010 Jun; 29(1):76. PubMed ID: 20565783
[TBL] [Abstract][Full Text] [Related]
5. Improving Antitumor Activity with N-Trimethyl Chitosan Entrapping Camptothecin in Colon Cancer and Lung Cancer.
Sun L; Li X; Li Z; Li Z; Gou M; Qian Z; Peng F
J Nanosci Nanotechnol; 2015 Sep; 15(9):6397-404. PubMed ID: 26716193
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
7. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity.
Yao L; Zhao X; Li Q; Zu Y; Fu Y; Zu B; Meng X; Liu C
Int J Pharm; 2012 Feb; 423(2):586-8. PubMed ID: 22193057
[TBL] [Abstract][Full Text] [Related]
9. A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids.
Li X; Kong X; Zhang J; Wang Y; Wang Y; Shi S; Guo G; Luo F; Zhao X; Wei Y; Qian Z
J Pharm Sci; 2011 Jan; 100(1):232-41. PubMed ID: 20533555
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
[TBL] [Abstract][Full Text] [Related]
14. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
[TBL] [Abstract][Full Text] [Related]
15. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
Tian H; Huang Y; He J; Zhang M; Ni P
ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
17. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis of polyrotaxane-camptothecin conjugates and evaluation of its anti-tumor effect].
Lai CL; Lai L; Zhao JB; Chen JH
Yao Xue Xue Bao; 2010 Jul; 45(7):920-5. PubMed ID: 20931793
[TBL] [Abstract][Full Text] [Related]
19. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles of ammonium palmitoyl glycol chitosan and solubilization of camptothecin.
Ranjha NM
PDA J Pharm Sci Technol; 2009; 63(1):81-7. PubMed ID: 19455944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
